The Journal will accept original and innovative submissions in English or Japanese from both members, and non-members of the Pharmaceutical Society of Japan, on the understanding that the work is unpublished and is not being considered for publication elsewhere.
The Journal publishes Reviews (Comprehensive and Short), Regular Articles, Notes, Communications, and Articles. The journal also publishes invited Reviews. Manuscripts in English or Japanese. With the exception of Reviews, manuscripts will be reviewed by two or more members of the editorial board, whose opinions will form the basis of the final decision by the editor.
Describing the research results of the author. Whilst the work need not be complete, supporting experimental data must be described.
Reviews are submitted by invitation from the editorial board, and encompass recent important scientific discoveries.
New, significant, innovative, and original findings are suitable as Regular Articles.
Papers containing new facts and important data derived from imcomplete or partial studies may be suitable as a Note. In general, the papers should not exceed 3 printed pages.
Surveys and experimental research including new, important findings. In general, the papers should not exceed 4 printed pages.
Communications should contain new, important information which has not been published and for which urgent publication is desirable. In general, the papers should not exceed 2 printed pages and should be submitted together with an explanatory statement justifying the need for urgent publication.
All manuscripts (in duplicate) should be submitted to:
Yakugaku Zasshi Editorial Office
The Pharmaceutical Society of Japan
2-12-15, Shibuya, Shibuya-ku, Tokyo 150-0002, Japan
All manuscripts should be typewritten in English or Japanese on A4-size white paper, double spaced. All subsequent pages should be numbered consecutively.
The title page (page 1) should start with the type of manuscript (Review (Comprehensive, Short), Regular Article, Notes etc.). This should be followed by the appropriate section for the manuscript (i.e. one of the follows: Physics, Inorganic Chemistry, Organic Chemistry, Medicinal Chemistry, Pharmacognosy, Analytical Chemistry, Biology/Biochemistry, Biopharmacy, Pharmacology, Hygienic Chemistry, Clinical Pharmacy, Pharmacy Education, Pharmaco-informatics, Annals of Pharmacy, Social Pharmacy), the title, name(s) of the author(s) and affiliation, mailing address in English and Japanese. For English-language manuscripts, only the name should be in Japanese and English (Japanese nationals only). An asterisk (*) should be added to the right of the corresponding author's name. For contribution from Japan, the corresponding author's name and address in Japanese, telephone number, fax number, and E-mail address should be given at the bottom left.
Page 2 should contain a summary of less than 250 words and 3 to 6 descriptive keywords, listed in order of importance. The first 3 keywords must be independent, as they will be used in a keyword combination in the index.
The text, acknowledgments, and references should be presented in this order. Figures, tables, and charts showing chemical structures should be collected at the end, each on a separate sheet. All pages should be numbered consecutively.
In principle, figures, tables, and charts showing chemical structures prepared by the author(s) will be used in the printed version of the journal. Figures and charts should be in English. All chemical structures, figures, and tables should be numbered consecutively with Arabic numbers, and figure titles and legends are to be typed consecutively on a separate sheet. All figures, tables and charts should be prepared on A4-size white paper.
Abbreviation must be spelled out in full at their initial appearance, followed by the abbreviation in parentheses. Thereafter, the abbreviation may be employed.
However, the following need not be defined: AIDS (acquired immunodeficiency syndrome), ATP (adenosine 5'-triphosphate), cAMP (adenosine 3',5'-cyclic monophosphate), cDNA (complementary DNA), CoA (coenzyme A), DNA (deoxyribonucleic acid), ED50 (50% effective dose), ESCA (electron spectroscopy for chemical analysis), ESR (electron spin resonance), FAB-MS (fast atom bombardment mass spectrometry), FAD (flavin adenine dinucleotide), GC-MS (gas chromatography-mass spectrometry), HOMO (highest occupied molecular orbital), HPLC (high-pressure liquid chromatography, high-performance liquid chromatography), IC50 (inhibitory concentration, 50%), IR (infrared), LD50 (50% lethal dose), LUMO (lowest unoccupied molecular orbital), MO (molecular orbital), mRNA (messenger RNA), MS (mass spectrum), NMR (nuclear magnetic resonance (as 13C-NMR, 1H-NMR)), P450 (as in cytochrome P450), RNA (ribonucleic acid), rRNA (ribosomal RNA), STO (Slater-type orbital (as STO 3G)), TLC (thin-layer chromatography), tRNA (transfer RNA), UV (ultraviolet)
The following units should be used: length (m, cm, mm, mm, nm, Å), mass (kg, g, mg, mg, ng, pg, mol, mmol), volume (l, ml, ml), time (s, min, h, d), temperature (ºC, K), radiation (Bq, Ci, dpm, Gy, rad), concentration (M, mM, mol/l, mmol/l, mg/ml, mg/ml, %, % (v/v), % (w/v), ppm, ppb)
Spectral and Elemental Analysis Data.
Please report spectral and elemental analysis data in the following format. 1H-NMR (CDCl3) d: 1.25 (3H, d, J=7.0 Hz), 3.55 (1H, q, J=7.0 Hz), 6.70 (1H, m). 13C-NMR (CDCl3) d: 20.9 (q), 71.5 (d), 169.9. IR (KBr) cm-1: 1720, 1050, 910. UV lmax (EtOH) nm (ε): 241 (10860), 288 (9380). UV lmax (H2O) nm (log ε): 280 (3.25). FAB-MS m/z: 332.1258 (Calcd for C18H20O6: 332.1259). MS m/z: 332 (M+), 180, 168. [a]23D-74.5 (c 1.0, MeOH). Anal. Calcd for C19H21NO3: C, 73.29; H, 6.80; N, 4.50. Found: C, 73.30; H, 6.88; N, 4.65.
Nomenclature.
The nomenclature of chemical compounds shall be in accordance with the nomenclature rules formulated by IUPAC. Alternatively, naming may conform to the nomenclature in the index of Chemical Abstracts or the Ring Index.
References.
References should be placed and numbered in the order of appearance in the text. Each number is to be positioned after the last relevant word with a right-half parenthesis mark, and all references should be collected together at the end of the text as References. Abbreviations for Journals should conform to Chemical Abstracts.
Examples of references are as follows:
For references, include the last names of all authors and initials for first and middle names. For references appearing on the main text, the last names of 2 authors only should be written. For references with 3 or more authors, write the name of one author and add et al.
When structure determination by X-ray crystallographic analysis is a central theme of the paper, the data required for registration with the Cambridge Crystallographic Data Base (CCDB) should be attached as supplementary material. Although this does not apply in cases where crystallographic analysis plays only a supplementary role, crystal data (unit cell parameters, space group, Z density) and R-factor should still be noted. Atomic coordinates will be printed when the structure is important. Bond lengths and angles, thermal parameters, and torsion angles will be printed when they are important for the issues addressed in the paper. When papers have been accepted, the authors are advised to register the data with CCDB.
Newly reported nucleotide sequences must be deposited in one of the data banks, DDBJ, GenBankTM, or EMBL, and an accession number must be obtained before the paper is accepted in the Associate Editor's office. Access to the information in the database must be available at the time of publication. A footnote will be included in the paper indicating that such a deposit has been made.
In scientific investigations involving human subjects, experiments should be performed in accordance with the ethical standards formulated in the Helsinki Declaration of 1964 (revised in 2000, cf. http//ohsr.od.nih.gov/). Similarly, animal experiments should follow the ethical standards formulated in the guidelines issued by the Science and International Affairs Bureau of the Japanese Ministry of Education, Science, Sports and Culture, No. 141, 1987 “Animal Experiments in Universities etc.”
Charge may be modified without preliminary announcement.
| Number of Pages Number of Reprints | 1-2 | 3-4 | 5-6 | 7-8 | 9-10 | Greater than 11 |
| 50 | ¥8000 | ¥9000 | ¥10000 | ¥11000 | ¥12000 | ¥13000 |
| 100 | ¥14400 | ¥16200 | ¥18000 | ¥19800 | ¥21600 | ¥23400 |
| 150 | ¥19200 | ¥21600 | ¥24000 | ¥26400 | ¥28800 | ¥31200 |
| 200 | ¥22400 | ¥25200 | ¥28000 | ¥30800 | ¥33600 | ¥36400 |
| More than 250 | ¥110 each | ¥120 each | ¥130 each | ¥150 each | ¥160 each | ¥180 each |